62.16
-1.08(-1.71%)
Currency In USD
| Previous Close | 63.24 |
| Open | 62.82 |
| Day High | 63.58 |
| Day Low | 60.97 |
| 52-Week High | 66.94 |
| 52-Week Low | 10.14 |
| Volume | 224,759 |
| Average Volume | 743,011 |
| Market Cap | 1.58B |
| PE | -8.15 |
| EPS | -7.63 |
| Moving Average 50 Days | 50.12 |
| Moving Average 200 Days | 28.12 |
| Change | -1.08 |
If you invested $1000 in Cidara Therapeutics, Inc. (CDTX) 10 years ago, it would be worth $222.32 as of August 19, 2025 at a share price of $62.16. Whereas If you bought $1000 worth of Cidara Therapeutics, Inc. (CDTX) shares 5 years ago, it would be worth $796.92 as of August 19, 2025 at a share price of $62.16.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cidara Therapeutics to Report Second Quarter 2025 Financial Results and Host Quarterly Conference Call on August 7, 2025
GlobeNewswire Inc.
Jul 24, 2025 12:00 PM GMT
SAN DIEGO, July 24, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced that it will report its se
Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
GlobeNewswire Inc.
Jul 01, 2025 8:59 PM GMT
SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company applying its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that the Compensation and
Cidara Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes
GlobeNewswire Inc.
Jun 30, 2025 12:00 PM GMT
SAN DIEGO, June 30, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company applying its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced its addition to the Russel